no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma
|
Fox, Elizabeth |
|
|
87 |
6 |
p. 807-815 |
article |
2 |
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers
|
Ma, Wen Wee |
|
|
87 |
6 |
p. 779-788 |
article |
3 |
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers
|
Kobayashi, Kazuo |
|
|
87 |
6 |
p. 767-777 |
article |
4 |
Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology
|
Liu, Stephanie N. |
|
|
87 |
6 |
p. 743-765 |
article |
5 |
Clinical significance of circulating tumor cells in the response to trastuzumab for HER2-negative metastatic gastric cancer
|
Matsushita, Daisuke |
|
|
87 |
6 |
p. 789-797 |
article |
6 |
Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients
|
Turiján-Espinoza, Eneida |
|
|
87 |
6 |
p. 843-853 |
article |
7 |
Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid
|
Volpato, Milene |
|
|
87 |
6 |
p. 879-880 |
article |
8 |
Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition
|
Gortany, Narges K. |
|
|
87 |
6 |
p. 827-842 |
article |
9 |
Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours
|
Vermunt, Marit A. C. |
|
|
87 |
6 |
p. 855-869 |
article |
10 |
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma
|
Shabsigh, Ahmad |
|
|
87 |
6 |
p. 799-805 |
article |
11 |
Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function
|
Mielczarek, Łukasz |
|
|
87 |
6 |
p. 723-742 |
article |
12 |
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
|
Ikesue, Hiroaki |
|
|
87 |
6 |
p. 871-877 |
article |
13 |
Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens
|
Kashanian, Sarah M. |
|
|
87 |
6 |
p. 817-826 |
article |